Next‐generation assessment of human epidermal growth factor receptor 2 gene ( ERBB2 ) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline
Author:
Affiliation:
1. Department of Pathology Memorial Sloan Kettering Cancer Center New York NYUSA
2. Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA
Publisher
Wiley
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14241
Reference26 articles.
1. Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
2. The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
4. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
5. Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular Characteristics;2024-08-19
2. Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy;Journal of Biophotonics;2024-01-28
3. HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer;American Journal of Clinical Pathology;2023-12-16
4. Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?;Clinics and Research in Hepatology and Gastroenterology;2023-02
5. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations;Modern Pathology;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3